72.5
Moleculin Biotech, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
45.6
FY23:
26.3
FY24:
5.19
FY25:
9.69
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.6
FY22:
11.8
FY23:
11.9
FY24:
11.7
FY25:
12.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
84.1
FY22:
57.4
FY23:
38.2
FY24:
16.9
FY25:
22.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.62
FY22:
4.82
FY23:
6.82
FY24:
5.36
FY25:
6.85
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.48
FY22:
0.41
FY23:
5.33
FY24:
0.36
FY25:
0.27
(positive)
Change from FY21 to FY25
millions USD
FY21:
79.0
FY22:
52.2
FY23:
26.1
FY24:
11.2
FY25:
15.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
84.1
FY22:
57.4
FY23:
38.2
FY24:
16.9
FY25:
22.1
All amounts in millions USD